Evidence map›Paper›PMID 26715620›Full record

ArticlemBio2015

Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.

Sonia Maciejewski, Joseph H C Nguyen, Fernando Gómez-Herreros, Felipe Cortés-Ledesma, Keith W Caldecott, Bert L Semler

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.Bioorganic & medicinal chemistry letters · 2019
    Article
  7. New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2).European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2018
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Enteroviral Infections in Infants.Newborn (Clarksville, Md.)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sonia MaciejewskiDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, California, USA.
Joseph H C NguyenDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, California, USA.
Fernando Gómez-HerrerosSchool of Life Sciences, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.
Felipe Cortés-LedesmaSchool of Life Sciences, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.
Keith W CaldecottSchool of Life Sciences, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.
Bert L SemlerDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, California, USA blsemler@uci.edu.
University of California, Irvine · USUniversity of Sussex · GB

Funding

Role of host cell protein TDP2 as VPg unlinkase during picornavirus replicationR01AI110782 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEMLER, BERT L · 2014 to 2018
$1.8M
Cancer Research UK 16771NIAID NIH HHS AI110782NIAID NIH HHS R01 AI110782
6 · The paper itself

Abstract

unlabelledViruses of the Enterovirus genus of picornaviruses, including poliovirus, coxsackievirus B3 (CVB3), and human rhinovirus, commandeer the functions of host cell proteins to aid in the replication of their small viral genomic RNAs during infection. One of these host proteins is a cellular DNA repair enzyme known as 5' tyrosyl-DNA phosphodiesterase 2 (TDP2). TDP2 was previously demonstrated to mediate the cleavage of a unique covalent linkage between a viral protein (VPg) and the 5' end of picornavirus RNAs. Although VPg is absent from actively translating poliovirus mRNAs, the removal of VPg is not required for the in vitro translation and replication of the RNA. However, TDP2 appears to be excluded from replication and encapsidation sites during peak times of poliovirus infection of HeLa cells, suggesting a role for TDP2 during the viral replication cycle. Using a mouse embryonic fibroblast cell line lacking TDP2, we found that TDP2 is differentially required among enteroviruses. Our single-cycle viral growth analysis shows that CVB3 replication has a greater dependency on TDP2 than does poliovirus or human rhinovirus replication. During infection, CVB3 protein accumulation is undetectable (by Western blot analysis) in the absence of TDP2, whereas poliovirus protein accumulation is reduced but still detectable. Using an infectious CVB3 RNA with a reporter, CVB3 RNA could still be replicated in the absence of TDP2 following transfection, albeit at reduced levels. Overall, these results indicate that TDP2 potentiates viral replication during enterovirus infections of cultured cells, making TDP2 a potential target for antiviral development for picornavirus infections. IMPORTANCE: Picornaviruses are one of the most prevalent groups of viruses that infect humans and livestock worldwide. These viruses include the human pathogens belonging to the Enterovirus genus, such as poliovirus, coxsackievirus B3 (CVB3), and human rhinovirus. Diseases caused by enteroviruses pose a major problem for public health and have significant economic impact. Poliovirus can cause paralytic poliomyelitis. CVB3 can cause hand, foot, and mouth disease and myocarditis. Human rhinovirus is the causative agent of the common cold, which has a severe economic impact due to lost productivity and severe health consequences in individuals with respiratory dysfunction, such as asthma. By gaining a better understanding of the enterovirus replication cycle, antiviral drugs against enteroviruses may be developed. Here, we report that the absence of the cellular enzyme TDP2 can significantly decrease viral yields of poliovirus, CVB3, and human rhinovirus, making TDP2 a potential target for an antiviral against enterovirus infections.

Indexed as

Virus ReplicationAnimalsDNA-Binding ProteinsDNA Repair EnzymesEnterovirusEnterovirus B, HumanEnterovirus InfectionsHeLa CellsHost-Pathogen InteractionsHumansMicePhosphoric Diester HydrolasesPoliovirusRhinovirusRNA, ViralTumor Necrosis Factor Receptor-Associated Peptides and ProteinsDNA-Binding ProteinsDNA Repair EnzymesPhosphoric Diester HydrolasesRNA, ViralTDP2 protein, mouseTumor Necrosis Factor Receptor-Associated Peptides and Proteinstyrosyl-DNA phosphodiesteraseViral Proteins

Identifiers

PMID26715620
PMCPMC4725011
OpenAlexW2206483804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.